Delivery Order SPE2DB20D3103-SPE2DB25FM7L7

Award Date 2/18/25
Potential Completion Date 2/19/25
Potential Value $1.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $2,029.92 firm fixed-price delivery order is for the supply of 4565916364 Rivastigmine 1.5 mg capsules to support federal healthcare programs. The contract has an ultimate completion date of September 25, 2024 and is not set aside for a specific business type. Amerisourcebergen holds a significant Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $1,353.28 firm fixed-price delivery order is for the supply of 4,566,438,493 units of the drug Rivastigmine 1.5 mg capsules. The contract has a completion date of November 15, 2024. Amerisourcebergen, a major pharmaceutical distributor and healthcare solutions provider, holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,353.28 firm fixed-price delivery order is for the supply of 100 units of the medication Rivastigmine 1.5 mg capsules. The contract has a completion date of July 10, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...
This federal contract award, valued at $2,173.58, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under the company's Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical...
Amerisourcebergen Drug Corp has been awarded a firm fixed price delivery order against its indefinite delivery contract with the Defense Logistics Agency (DLA) Troop Support Medical. Valued at $1,649.04, this order is for the supply of 4562926313 Rivastigmine 3 mg capsules, 60 count, to support DLA medical facilities. Performance will take place at Amerisourcebergen's headquarters in Conshohocken, Pennsylvania, with completion by November 29, 2023. No set-aside designation was applied to this...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,779.47 firm fixed-price delivery order is for the supply of NAMZARIC 28 MG-10 MG CAPSULE 30S, a medication used to treat Alzheimer's disease. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical, which serves as a primary...
This federal contract award, valued at $2,990.47, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Donepezil HCL 23 mg tablets, a medication commonly used to treat Alzheimer's disease. The contract is a delivery order, with a firm fixed-price pricing type, and an ultimate completion date of November 1, 2023. It is not designated as a set-aside contract....
This federal contract award, valued at $1,185.16, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The contract is a Delivery Order under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which has a ceiling value of up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for...
This federal contract award, valued at $1,704.52, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of AMNESTEEM 40 MG CAPSULE 30S, a medical product, with a completion date of December 19, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999...
This federal contract award, valued at $1,142.98, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is a Delivery Order for the supply of AMNESTEEM 40 MG CAPSULE 30S, a pharmaceutical product, with a completion date of February 19, 2025. The award is part of a larger Indefinite Delivery Contract (IDC) worth $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB25FM7L7
    Delivery Order

This federal contract award, valued at $1,062.32, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order (DO) under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which is valued at $999,999,999 and runs through November 2026.

The contract is for the delivery of 4567299322 RIVASTIGMINE 6 MG CAPSULE 60S, a pharmaceutical product used in the treatment of dementia. The contract has a completion date of February 19, 2025 and utilizes a Firm Fixed Price (FFP) pricing structure. The contract was not designated as a set-aside requirement, indicating open competition. Amerisourcebergen, as the prime contractor, will be responsible for supplying this pharmaceutical product to support the healthcare needs of military personnel, veterans, and other federal beneficiaries through the DLA's medical supply programs.

Generated 5/22/25, 8:14 PM